Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 ,inter alia, to consider and approve Financial results ....
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Tuesday, May 6, 2025. On the agenda are (a) approval of audited financial results for the quarter and full year ended March 31, 2025, and (b) consideration of a dividend recommendation for FY25, if any. No financial numbers or outcomes are disclosed in this filing — it is a routine advance notice required under SEBI listing rules ahead of the results announcement.
This is a procedural filing, not a material announcement. Shareholders should watch the actual results on or after May 6 for performance details and any dividend announcement, which could affect near-term stock sentiment.